Maintenance therapy is now clinically proven to postpone disease progression in advanced CTCL which could significantly change current clinical practice RESMAIN is one of the largest clinical trials in cutaneous T-cell lymphoma (CTCL) to-date Resminostat (Kinselby) as a maintenance treatment for advanced CTCL, is clinically proven to postpone disease progression in patients – a new treatment […]